Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
Go back to Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease| (NASDAQ: LNTH) | Delayed: 100.25 -0.14 (0.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $100.39 | 52 Week High | $10.70 | |||
| Open | $100.51 | 52 Week Low | $1.76 | |||
| Day High | $100.51 | P/E | N/A | |||
| Day Low | $100.18 | EPS | $0.00 | |||
| Volume | 1,212,393 | |||||
